The FDA granted Seres Therapeutics’ SER-287 orphan drug designation. SER-287 treats pediatric ulcerative colitis.
The FDA approved Ferring Pharmaceutical’s Clenpiq, a low-volume colonoscopy prep solution.
Takeda appointed Toshio Fujimoto, MD, to serve as the general manager of the Health Innovation Park in Shonan, Japan.
More articles on gastroenterology:
GI leader to know: Dr. Essam Quraishi of Gastrointestinal & Liver Consultants
Stock market week-in-review for 5 large GI companies — Nov. 27 to Dec. 1
How AI is improving polyp detection
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.